Intas Pharma slashes cancer drug prices

Pharma/BioPharma |  News | 0 Comment | 06 Oct, 2017

Intas Pharmaceuticals Ltd has announced that it will cut down the prices of Bevacizumab drug by 60 per cent. The company states that it will bring relief to a large number of cancer patient...Read more

Typhoid vaccine by Bharat Biotech shows efficacy

Pharma/BioPharma |  News | 0 Comment | 03 Oct, 2017

Vaccine Innovator Bharat Biotech has announced that its next generation typhoid vaccine, Typbar-TCV, has demonstrated its safety and efficacy in a high risk human challenge clinical study c...Read more

Hilleman Laboratories receives Indo-Swedish grant for developing - Oral Cholera Vaccine

Pharma/BioPharma |  News | 0 Comment | 28 Sep, 2017

Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, received a 6 million krona (737281.80 US Dollar) Indo – Swedish grant for the project ‘Improve...Read more

MSD announces entry of Keytruda in India

Pharma/BioPharma |  News | 0 Comment | 13 Sep, 2017

US biopharmaceutical giant Merck, Sharpe and Dohme (MSD) has launched its blockbuster cancer drug ‘Keytruda’ (pembrolizumab) in India around a year after it first received appro...Read more

Kidney stone drug from Strides Shasun receives USFDA approval

Pharma/BioPharma |  News | 0 Comment | 12 Sep, 2017

Strides Shasun Limited has received approval from the United States Food & Drug Administration (USFDA) for Potassium Citrate Extended-Release Tablets USP, 5 mEq, 10 mEq, and 15 mEq Acc...Read more

Dr. Reddy's launches antidepressants in the US market

Pharma/BioPharma |  News | 0 Comment | 06 Sep, 2017

Dr. Reddy’s Laboratories Ltd. has launched Bupropion Hydrochloride Extended-Release Tablets, USP (XL), 150 mg and 300 mg, a therapeutic equivalent generic version of Wellbutrin XL&nbs...Read more

JDRF joins Biocon for global diabetes study

Pharma/BioPharma |  News | 0 Comment | 06 Sep, 2017

Asia’s premier biopharmaceuticals company, and JDRF, the leading global organization funding type 1 diabetes (T1D) research and advocacy worldwide, jointly announced a JDRF  part...Read more

Dr. Reddy’s launches Cefixime for Oral Suspension

Pharma/BioPharma |  News | 0 Comment | 28 Aug, 2017

Dr. Reddy’s Laboratories Ltd. has announced that it has launched Cefixime for Oral Suspension, USP 100 mg/5mL and 200 mg/5mL, a therapeutic equivalent generic version of Suprax (cefix...Read more

MDR TB drug by Otsuka reaches India

Pharma/BioPharma |  News | 0 Comment | 25 Aug, 2017

Japanese drug maker Otsuka Pharmaceutical has granted US pharmaceutical firm Mylan’s subsidiary an exclusive license to supply to India and South Africa a drug to treat patients with ...Read more

Growing pharma sector to boost laboratory, analysis and diagnostics market in India

Pharma/BioPharma |  News | 0 Comment | 17 Aug, 2017

The Indian pharma industry has been growing at a compounded annual growth rate (CAGR) of more than 15% over the last five years and is expected to grow to US$ 100 billion by 2025. The Unio...Read more

National Bio Entrepreneurship Competition launched by Y.S. Chowdary

Pharma/BioPharma |  News | 0 Comment | 17 Aug, 2017

The National Bio Entrepreneurship Competition which is a national platform to attract, identify and nurture bio-entrepreneurs with path-breaking ideas for societal impact has been launched ...Read more

UBM India announces 4rth edition of PharmaLytica event

Pharma/BioPharma |  News | 0 Comment | 04 Aug, 2017

UBM India, organizers of CPhI / P-MEC India, the leading global pharma trade show and conference, announced the 4th edition of PharmaLytica 2017. The two day event will be held at the HITEX...Read more

Cipla to explore marketing tie-up with Novartis

Pharma/BioPharma |  News | 0 Comment | 14 Jul, 2017

Cipla, India’s third largest drug maker, and Swiss giant Novartis are in early-stage discussions to jointly market asthma drug Xolair, just months after they ended a legal battle over...Read more

Takeda collaborates with Biological E

Pharma/BioPharma |  News | 0 Comment | 27 Jun, 2017

Japan’s Takeda and Biological E. Ltd. have agreed to collaborate on affordable combination vaccines. Takeda will transfer its measles and acellular pertussis vaccine bulk production ...Read more

Leo Pharma invests into Novopyxis

Pharma/BioPharma |  News | 0 Comment | 22 Jun, 2017

Leo Pharma announced an investment in the biotechnology company Novopyxis to support the development of an early-stage drug delivery device designed to increase the penetration of topical t...Read more

Glenmark starts a pact with APC Therapeutics

Pharma/BioPharma |  News | 0 Comment | 21 Jun, 2017

Domestic pharma major Glenmark Pharmaceuticals has entered into a licensing agreement with Boston-based APC Therapeutics Inc for development of a potential cancer treatment drug. Under the...Read more

AstraZeneca India receives marketing approval for Symbicort 320

Pharma/BioPharma |  News | 0 Comment | 20 Jun, 2017

AstraZeneca Pharma India Limited (AstraZeneca India), an international biopharmaceutical company has received marketing authorisation from the Drug Controller General of India (DCGI) for Sy...Read more

FDA approval to Zydus for migraine drug

Pharma/BioPharma |  News | 0 Comment | 20 Jun, 2017

Indian pharmaceutical major Zydus Cadila has managed to receive the final approval from the US health regulator Food and Drug Administration (USFDA) to market Eletriptan Hydrobromide tablet...Read more